- Home
- BORR vs ANIP Comparison
BORR vs ANIP Comparison
Compare BORR & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BORR
- ANIP
- Stock Information
- Founded
- BORR 2016
- ANIP 2001
- Country
- BORR Bermuda
- ANIP United States
- Employees
- BORR N/A
- ANIP N/A
- Industry
- BORR Oil & Gas Production
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- BORR Energy
- ANIP Health Care
- Exchange
- BORR Nasdaq
- ANIP Nasdaq
- Market Cap
- BORR 1.3B
- ANIP 1.3B
- IPO Year
- BORR 2019
- ANIP N/A
- Fundamental
- Price
- BORR $4.04
- ANIP $56.91
- Analyst Decision
- BORR Buy
- ANIP Buy
- Analyst Count
- BORR 1
- ANIP 6
- Target Price
- BORR $9.00
- ANIP $76.80
- AVG Volume (30 Days)
- BORR 4.6M
- ANIP 281.6K
- Earning Date
- BORR 11-06-2024
- ANIP 11-08-2024
- Dividend Yield
- BORR 7.41%
- ANIP N/A
- EPS Growth
- BORR N/A
- ANIP N/A
- EPS
- BORR 0.33
- ANIP N/A
- Revenue
- BORR $968,100,000.00
- ANIP $555,456,000.00
- Revenue This Year
- BORR $33.10
- ANIP $23.69
- Revenue Next Year
- BORR $12.85
- ANIP $18.95
- P/E Ratio
- BORR $12.01
- ANIP N/A
- Revenue Growth
- BORR 38.38
- ANIP 23.60
- 52 Week Low
- BORR $3.76
- ANIP $48.20
- 52 Week High
- BORR $7.61
- ANIP $70.81
- Technical
- Relative Strength Index (RSI)
- BORR 40.76
- ANIP 46.33
- Support Level
- BORR $3.83
- ANIP $53.93
- Resistance Level
- BORR $4.23
- ANIP $63.23
- Average True Range (ATR)
- BORR 0.17
- ANIP 2.41
- MACD
- BORR 0.04
- ANIP -0.34
- Stochastic Oscillator
- BORR 41.79
- ANIP 32.04
About BORR Borr Drilling Limited
Borr Drilling Ltd is a drilling contractor that owns and operates jack-up rigs of modern and high-specification designs providing drilling services to the oil and gas exploration and production industry. The company operates a fleet of 16 jack-up drilling rigs. Geographically the activities are carried out through Norway.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.